Subcutaneous Epcoritamab in Patients with Richter's Syndrome: Early Results from Phase 1b/2 Trial (EPCORE CLL-1)

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.850-851
Main Authors: Kater, Arnon P., Ye, J Christine, Sandoval-Sus, Jose, Bellido, Mar, Christensen, Jacob Haaber, Mato, Anthony R., Janssens, Ann, Oki, Toshihiko, Hoehn, Daniela, Rios, Marcia, Kuznetsova, Alexandra, Valentin, Rebecca, Eradat, Herbert
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1858-b4e94a785b4c1751afcf20771dadcebba3e9c8bfad222fe3ce63e347b31042113
cites
container_end_page 851
container_issue Supplement 1
container_start_page 850
container_title Blood
container_volume 140
creator Kater, Arnon P.
Ye, J Christine
Sandoval-Sus, Jose
Bellido, Mar
Christensen, Jacob Haaber
Mato, Anthony R.
Janssens, Ann
Oki, Toshihiko
Hoehn, Daniela
Rios, Marcia
Kuznetsova, Alexandra
Valentin, Rebecca
Eradat, Herbert
description
doi_str_mv 10.1182/blood-2022-158298
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_158298</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122018924</els_id><sourcerecordid>S0006497122018924</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1858-b4e94a785b4c1751afcf20771dadcebba3e9c8bfad222fe3ce63e347b31042113</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhoMoOD9-gHe5Uy_ictJ2TfVKSv2AwsY2r0OSnrJI146kVfbv7ZzXXh14Oc_Ly0PIDfAHACmmpum6igkuBINEikyekAkkQjLOBT8lE875jMVZCufkIoRPziGORDIhu9Vg7NDrFrsh0GJnO-96vdWGupYudO-w7QP9dv2GLp3d9OhvA13t28p3W3ykhfbNni4xDM34Vo8hXWx0QApmKujaO93Qu2KRz5cFzcuSwf0VOat1E_D6716Sj5dinb-xcv76nj-XzIJMJDMxZrFOZWJiC2kCura14GkKla4sGqMjzKw0ta6EEDVGFmcRRnFqIuCxAIguCRx7re9C8FirnXdb7fcKuDooU7_K1EGZOiobmacjg-OwL4deBTsKsFg5j7ZXVef-oX8A84Nzyg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Subcutaneous Epcoritamab in Patients with Richter's Syndrome: Early Results from Phase 1b/2 Trial (EPCORE CLL-1)</title><source>ScienceDirect Journals</source><creator>Kater, Arnon P. ; Ye, J Christine ; Sandoval-Sus, Jose ; Bellido, Mar ; Christensen, Jacob Haaber ; Mato, Anthony R. ; Janssens, Ann ; Oki, Toshihiko ; Hoehn, Daniela ; Rios, Marcia ; Kuznetsova, Alexandra ; Valentin, Rebecca ; Eradat, Herbert</creator><creatorcontrib>Kater, Arnon P. ; Ye, J Christine ; Sandoval-Sus, Jose ; Bellido, Mar ; Christensen, Jacob Haaber ; Mato, Anthony R. ; Janssens, Ann ; Oki, Toshihiko ; Hoehn, Daniela ; Rios, Marcia ; Kuznetsova, Alexandra ; Valentin, Rebecca ; Eradat, Herbert</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-158298</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.850-851</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1858-b4e94a785b4c1751afcf20771dadcebba3e9c8bfad222fe3ce63e347b31042113</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006497122018924$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27901,27902,45756</link.rule.ids></links><search><creatorcontrib>Kater, Arnon P.</creatorcontrib><creatorcontrib>Ye, J Christine</creatorcontrib><creatorcontrib>Sandoval-Sus, Jose</creatorcontrib><creatorcontrib>Bellido, Mar</creatorcontrib><creatorcontrib>Christensen, Jacob Haaber</creatorcontrib><creatorcontrib>Mato, Anthony R.</creatorcontrib><creatorcontrib>Janssens, Ann</creatorcontrib><creatorcontrib>Oki, Toshihiko</creatorcontrib><creatorcontrib>Hoehn, Daniela</creatorcontrib><creatorcontrib>Rios, Marcia</creatorcontrib><creatorcontrib>Kuznetsova, Alexandra</creatorcontrib><creatorcontrib>Valentin, Rebecca</creatorcontrib><creatorcontrib>Eradat, Herbert</creatorcontrib><title>Subcutaneous Epcoritamab in Patients with Richter's Syndrome: Early Results from Phase 1b/2 Trial (EPCORE CLL-1)</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kF1LwzAUhoMoOD9-gHe5Uy_ictJ2TfVKSv2AwsY2r0OSnrJI146kVfbv7ZzXXh14Oc_Ly0PIDfAHACmmpum6igkuBINEikyekAkkQjLOBT8lE875jMVZCufkIoRPziGORDIhu9Vg7NDrFrsh0GJnO-96vdWGupYudO-w7QP9dv2GLp3d9OhvA13t28p3W3ykhfbNni4xDM34Vo8hXWx0QApmKujaO93Qu2KRz5cFzcuSwf0VOat1E_D6716Sj5dinb-xcv76nj-XzIJMJDMxZrFOZWJiC2kCura14GkKla4sGqMjzKw0ta6EEDVGFmcRRnFqIuCxAIguCRx7re9C8FirnXdb7fcKuDooU7_K1EGZOiobmacjg-OwL4deBTsKsFg5j7ZXVef-oX8A84Nzyg</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Kater, Arnon P.</creator><creator>Ye, J Christine</creator><creator>Sandoval-Sus, Jose</creator><creator>Bellido, Mar</creator><creator>Christensen, Jacob Haaber</creator><creator>Mato, Anthony R.</creator><creator>Janssens, Ann</creator><creator>Oki, Toshihiko</creator><creator>Hoehn, Daniela</creator><creator>Rios, Marcia</creator><creator>Kuznetsova, Alexandra</creator><creator>Valentin, Rebecca</creator><creator>Eradat, Herbert</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Subcutaneous Epcoritamab in Patients with Richter's Syndrome: Early Results from Phase 1b/2 Trial (EPCORE CLL-1)</title><author>Kater, Arnon P. ; Ye, J Christine ; Sandoval-Sus, Jose ; Bellido, Mar ; Christensen, Jacob Haaber ; Mato, Anthony R. ; Janssens, Ann ; Oki, Toshihiko ; Hoehn, Daniela ; Rios, Marcia ; Kuznetsova, Alexandra ; Valentin, Rebecca ; Eradat, Herbert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1858-b4e94a785b4c1751afcf20771dadcebba3e9c8bfad222fe3ce63e347b31042113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kater, Arnon P.</creatorcontrib><creatorcontrib>Ye, J Christine</creatorcontrib><creatorcontrib>Sandoval-Sus, Jose</creatorcontrib><creatorcontrib>Bellido, Mar</creatorcontrib><creatorcontrib>Christensen, Jacob Haaber</creatorcontrib><creatorcontrib>Mato, Anthony R.</creatorcontrib><creatorcontrib>Janssens, Ann</creatorcontrib><creatorcontrib>Oki, Toshihiko</creatorcontrib><creatorcontrib>Hoehn, Daniela</creatorcontrib><creatorcontrib>Rios, Marcia</creatorcontrib><creatorcontrib>Kuznetsova, Alexandra</creatorcontrib><creatorcontrib>Valentin, Rebecca</creatorcontrib><creatorcontrib>Eradat, Herbert</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kater, Arnon P.</au><au>Ye, J Christine</au><au>Sandoval-Sus, Jose</au><au>Bellido, Mar</au><au>Christensen, Jacob Haaber</au><au>Mato, Anthony R.</au><au>Janssens, Ann</au><au>Oki, Toshihiko</au><au>Hoehn, Daniela</au><au>Rios, Marcia</au><au>Kuznetsova, Alexandra</au><au>Valentin, Rebecca</au><au>Eradat, Herbert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Subcutaneous Epcoritamab in Patients with Richter's Syndrome: Early Results from Phase 1b/2 Trial (EPCORE CLL-1)</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>850</spage><epage>851</epage><pages>850-851</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-158298</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.850-851
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_158298
source ScienceDirect Journals
title Subcutaneous Epcoritamab in Patients with Richter's Syndrome: Early Results from Phase 1b/2 Trial (EPCORE CLL-1)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T18%3A23%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Subcutaneous%20Epcoritamab%20in%20Patients%20with%20Richter's%20Syndrome:%20Early%20Results%20from%20Phase%201b/2%20Trial%20(EPCORE%20CLL-1)&rft.jtitle=Blood&rft.au=Kater,%20Arnon%20P.&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=850&rft.epage=851&rft.pages=850-851&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-158298&rft_dat=%3Celsevier_cross%3ES0006497122018924%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1858-b4e94a785b4c1751afcf20771dadcebba3e9c8bfad222fe3ce63e347b31042113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true